Issue - meetings

Coronavirus contingency arrangements

Meeting: 13/07/2021 - Lead Member for Strategic Management and Economic Development (Item 3)

3 Coronavirus (Covid-19) contingency arrangements pdf icon PDF 281 KB

Report by the Assistant Chief Executive

Minutes:

3.1       The Leader and Lead Member considered a report by the Assistant Chief Executive.

 

DECISIONS

3.2       The Leader and Lead Member RESOLVED to (1) agree to the continuation of the delegation of authority to the Chief Executive to take any executive decision which she considers appropriate in response to Covid-19; and

 

(2) review the delegation in January 2022 or as soon as practicable thereafter.

 

Reasons

 

3.3       The continued delegation ensures that provision continues to be in place to provide for executive decisions to be taken in response to Covid-19.


Meeting: 29/10/2020 - Lead Member for Strategic Management and Economic Development (Item 12)

12 Coronavirus (Covid-19) contingency arrangements pdf icon PDF 282 KB

Report by the Assistant Chief Executive

Minutes:

12.1     The Leader and Lead Member for Strategic Management and Economic Development considered a report by the Assistant Chief Executive.

 

DECISIONS

 

12.2     The Leader and Lead Member RESOLVED to (1) agree to the continuation of the delegation of authority to the Chief Executive to take any executive decision which she considers appropriate in response to Covid-19; and

 

(2) review the delegation in July 2021 or as soon as practicable thereafter.

 

Reasons

 

12.3     The Covid-19 situation continues to require decisions to be taken at short notice.  Although arrangements are in place for Lead Member decisions to be taken virtually it may, in certain situations, not be possible or prudent to wait for the Lead Member to take the decisions at a formal meeting.   The current delegation will be extended to July 2021 to ensure that provision continues to be in place to provide for essential urgent executive decisions to be taken in response to Covid-19.